Published in J Virol on October 01, 1992
MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc Natl Acad Sci U S A (2000) 1.78
Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells. J Virol (1993) 1.47
Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen. Proc Natl Acad Sci U S A (1998) 1.07
Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J Virol (1994) 1.02
Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies. J Virol (1995) 0.95
Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J Virol (1993) 0.95
Schistosoma mansoni phosphoenolpyruvate carboxykinase, a novel egg antigen: immunological properties of the recombinant protein and identification of a T-cell epitope. Infect Immun (2000) 0.93
Binding motifs predict major histocompatibility complex class II-restricted epitopes in the Sendai virus M protein. J Virol (1995) 0.86
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol (1985) 13.99
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (1991) 13.90
Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell (1985) 5.25
Immunology. The ins and outs of antigen processing and presentation. Nature (1986) 4.08
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med (1990) 3.73
Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol (1988) 2.67
Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol Rev (1987) 2.64
Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science (1988) 2.59
Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J Exp Med (1990) 2.58
Myristoylation is important at multiple stages in poliovirus assembly. J Virol (1991) 2.36
Cytotoxic T lymphocytes against a soluble protein. Nature (1987) 2.36
Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein). Virology (1980) 2.07
Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. Proc Natl Acad Sci U S A (1985) 1.79
Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats. Proc Natl Acad Sci U S A (1982) 1.78
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120. AIDS (1990) 1.71
Transformation of a human poliovirus receptor gene into mouse cells. Proc Natl Acad Sci U S A (1986) 1.68
Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J Virol (1991) 1.50
Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J Immunol (1992) 1.42
The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins. J Exp Med (1978) 1.39
Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. J Exp Med (1985) 1.37
Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry? Immunol Today (1989) 1.28
Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. J Virol (1991) 1.28
Poliomyelitis in hypogammaglobulinemics. J Infect Dis (1973) 1.27
Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J Immunol (1992) 1.26
Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology (1987) 1.23
In vitro culture of coxsackievirus group B, type 3 immune spleen cells on infected endothelial cells and biological activity of the cultured cells in vivo. Infect Immun (1984) 1.17
Immunotherapy for virus infection. Curr Top Microbiol Immunol (1987) 1.00
Identification of T-helper epitopes in the VP1 capsid protein of poliovirus. J Virol (1992) 1.00
Experimental poliomyelitis following intramuscular virus injection. III. The effect of passive antibody on paralysis and viremia. Bull Johns Hopkins Hosp (1962) 0.89
Murine monoclonal antibodies directed against the transmembrane protein gp41 of human immunodeficiency virus type 1 enhance its infectivity. J Gen Virol (1992) 0.86
Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells. Eur J Immunol (1990) 0.79
Three-dimensional structure of poliovirus at 2.9 A resolution. Science (1985) 11.47
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature (1987) 5.26
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J (1989) 4.12
Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature (1997) 3.57
Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J Virol (1994) 2.90
Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol (1988) 2.67
Delayed ipsilateral parenchymal hemorrhage following flow diversion for the treatment of anterior circulation aneurysms. AJNR Am J Neuroradiol (2012) 2.49
Myristoylation is important at multiple stages in poliovirus assembly. J Virol (1991) 2.36
The poliovirus 135S particle is infectious. J Virol (1996) 2.10
Synthesis of murine leukemia virus plus strong stop DNA initiates at a unique site. J Biol Chem (1982) 2.03
'The metabolism of tumours': 70 years later. Novartis Found Symp (2001) 1.99
Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust (1996) 1.94
Challenges to implementation of the new Coroners' (Amendment) Rules 2005: experience from a tertiary paediatric pathology centre. Med Sci Law (2007) 1.92
Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. Proc Natl Acad Sci U S A (1985) 1.79
Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats. Proc Natl Acad Sci U S A (1982) 1.78
Canadian experience with the pipeline embolization device for repair of unruptured intracranial aneurysms. AJNR Am J Neuroradiol (2012) 1.74
Energy density but not fat content of foods affected energy intake in lean and obese women. Am J Clin Nutr (1999) 1.70
Healthy ageing is associated with reduced and delayed disability. Age Ageing (2000) 1.69
Vitellogenin induction and reduced serum testosterone concentrations in feral male carp (Cyprinus carpio) captured near a major metropolitan sewage treatment plant. Environ Health Perspect (1996) 1.69
Characterization of the ion channels formed by poliovirus in planar lipid membranes. J Virol (1997) 1.67
Moderate alcohol intake is associated with survival in the elderly: the Dubbo Study. Med J Aust (2000) 1.55
Alcohol intake and survival in the elderly: a 77 month follow-up in the Dubbo study. Aust N Z J Med (1996) 1.51
A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus. J Virol (1993) 1.51
Poliovirus 2C region functions during encapsidation of viral RNA. J Virol (1997) 1.44
Extrahepatic biliary cystadenomas and cystadenocarcinoma. Report of seven cases and review of the literature. Ann Surg (1995) 1.43
Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects. J Mol Biol (2000) 1.41
Stability and gap phenomena for Yang-Mills fields. Proc Natl Acad Sci U S A (1979) 1.39
High density lipoproteins, genetic polymorphism for apo A-I and coronary artery disease. Aust N Z J Med (1991) 1.39
Lipoprotein(a) concentration in diabetes: relationship to proteinuria and diabetes control. Aust N Z J Med (1992) 1.39
Some cohomology classes in principal fiber bundles and their application to riemannian geometry. Proc Natl Acad Sci U S A (1971) 1.39
Coronary risk factors six to twelve months after coronary artery bypass surgery. 1986 compared with 1990. Med J Aust (1991) 1.38
Is the 135S poliovirus particle an intermediate during cell entry? J Virol (2000) 1.36
Pseudomonas aeruginosa mediated apoptosis requires the ADP-ribosylating activity of exoS. Microbiology (2000) 1.36
Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke (1998) 1.29
Hospital prescribing errors: epidemiological assessment of predictors. Br J Clin Pharmacol (2002) 1.27
Identification and characterization of a protein covalently bound to DNA of minute virus of mice. J Virol (1986) 1.26
Predicting drug use: application of behavioral theories of choice. Addict Behav (1999) 1.24
Pimecrolimus: a review. J Eur Acad Dermatol Venereol (2003) 1.21
Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B. Virology (1991) 1.15
Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. J Virol (1999) 1.14
Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. Atherosclerosis (2001) 1.12
Coronary artery disease is not associated with the E298-->D variant of the constitutive, endothelial nitric oxide synthase gene. Clin Genet (1998) 1.12
Poliovirus: new insights from an old paradigm. Structure (1996) 1.10
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Ann Oncol (2008) 1.08
Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus. J Biol Chem (1985) 1.06
Efficient analysis of nonviable poliovirus capsid mutants. J Virol (1993) 1.04
Diabetes and coronary heart disease. N Engl J Med (1998) 1.04
Inheritance of physical fitness in 10-yr-old twins and their parents. Med Sci Sports Exerc (1996) 1.01
Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia. Atherosclerosis (1998) 1.01
Discontinuation rates for use of statins are high. BMJ (2000) 1.01
Identification of T-helper epitopes in the VP1 capsid protein of poliovirus. J Virol (1992) 1.00
Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide. Biochem Biophys Res Commun (1997) 0.99
Folding and processing of the capsid protein precursor P1 is kinetically retarded in neutralization site 3B mutants of poliovirus. J Virol (1992) 0.97
Predictors of mortality in the prospective Dubbo study of Australian elderly. Aust N Z J Med (1996) 0.96
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol (2007) 0.96
Low-energy tautomers and conformers of neutral and protonated arginine. J Am Chem Soc (2001) 0.96
Measurement properties of the Center for Epidemiological Studies Depression Scale: an Australian community study of aged persons. J Gerontol B Psychol Sci Soc Sci (1995) 0.95
Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors. Cold Spring Harb Symp Quant Biol (2005) 0.95
Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J Virol (1993) 0.95
Size, fatness and relative fat distribution of males of contrasting maturity status during adolescence and as adults. Int J Obes Relat Metab Disord (1994) 0.94
Diabetes, mortality and coronary heart disease in the prospective Dubbo study of Australian elderly. Aust N Z J Med (1996) 0.93
Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol (1996) 0.93
Dubbo study of the elderly: sociological and cardiovascular risk factors at entry. Aust N Z J Med (1991) 0.93
On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis (1995) 0.93
High-altitude pulmonary edema. Characteristics of lung lavage fluid. JAMA (1986) 0.93
The Dubbo study of the health of elderly: correlates of coronary heart disease at study entry. J Am Geriatr Soc (1991) 0.93
Withholding consent to lifesaving treatment: three cases. BMJ (1995) 0.92
Neuropsychological study in treated thyroid dysgenesis. Acta Paediatr Scand Suppl (1979) 0.92
Heritable, population-wide damage to cells as the driving force of neoplastic transformation. Proc Natl Acad Sci U S A (1995) 0.92
Risk factors for coronary heart disease in the prospective Dubbo Study of Australian elderly. Atherosclerosis (1995) 0.92
Effect of chronic oral moricizine and intravenous epinephrine on ventricular fibrillation and defibrillation thresholds. Pacing Clin Electrophysiol (1996) 0.92
SPARC: a Ca2+-binding extracellular protein associated with endothelial cell injury and proliferation. J Mol Cell Cardiol (1989) 0.91
Prediction of gentamicin serum levels using a one-compartment open linear pharmacokinetic model. Am J Hosp Pharm (1978) 0.91
Lipid-alginate interactions render changes in phospholipid bilayer permeability. Biochim Biophys Acta (1991) 0.91
The Dubbo study: an Australian prospective community study of the health of elderly. Aust N Z J Med (1990) 0.91
A multimodal system for reconstruction and quantification of neurologic structures. Anal Quant Cytol Histol (1986) 0.90
An evaluation of the hemostatic effect of externally applied notoginseng and notoginseng total saponins. J Clin Pharmacol (2000) 0.89
Physical activity and growth, maturation and performance: a longitudinal study. Med Sci Sports Exerc (1992) 0.89
Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol (2002) 0.88
Pulsatile release of gonadotropin-releasing hormone from hypothalamic explants is restrained by blockade of N-methyl-D,L-aspartate receptors. Endocrinology (1989) 0.88
Stabilization of poliovirus against heat inactivation. Biochem Biophys Res Commun (1989) 0.88
Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol (2000) 0.87
Fasting plasma glucose in non-diabetic elderly women predicts increased all-causes mortality and coronary heart disease risk. Aust N Z J Med (2000) 0.87
Chronological and biological age as related to physical fitness in boys 12 to 19 years. Ann Hum Biol (1981) 0.86
Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol (1993) 0.86
Mode of spread to and within the central nervous system after oral infection of neonatal mice with the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1995) 0.86
Neoplastic development: paradoxical relation between impaired cell growth at low population density and excessive growth at high density. Proc Natl Acad Sci U S A (1995) 0.86
Multiple medication use in the elderly. Use of prescription and non-prescription drugs in an Australian community setting. Med J Aust (1992) 0.85
Cellular aging, destabilization, and cancer. Proc Natl Acad Sci U S A (1996) 0.85
Development of a high-efficiency method for gene marking of Dunning prostate cancer cell lines with the enzyme beta-galactosidase. Prostate (1996) 0.85
Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. Int J Radiat Oncol Biol Phys (1993) 0.85
Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis (1987) 0.84
Short-term effects of a progestational contraceptive drug on food intake, resting energy expenditure, and body weight in young women. Am J Clin Nutr (2001) 0.84
Human gene marker/therapy clinical protocols. Hum Gene Ther (2000) 0.84
Chronic bronchitis and risk of coronary heart disease. Lancet (1996) 0.84
Structure of the human gene encoding the associated microfibrillar protein (MFAP1) and localization to chromosome 15q15-q21. Genomics (1994) 0.83